FDA Clearance Tracker · P150040
VISUMAX FEMTOSECOND LASER
Last checked: Nov 19, 2026Latest source record: Sep 13, 2016 (this decision)Source: openFDAMethods & limitations
Decided
Sep 13, 2016
Approved
Time to decision
319 days
Received Oct 30, 2015. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P150040
- Device name
- VISUMAX FEMTOSECOND LASER
- Applicant
- Carl Zeiss Meditec, Inc.
- Applicant location
- Dublin, CA
- Received
- Oct 30, 2015
- Decided
- Sep 13, 2016
- Decision
- Approved
- Supplements
- 23 in FDA's data for this PMA. See them on the FDA record
Device type
- Device class
- Class III
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
Approval for the VisuMax Femtosecond Laser. This device is indicated for use in small incision lenticule extraction (SMILE) for the reduction or elimination of myopia >= -1.00 D to <= -8.00 D, with <= -0.50 D cylinder and MRSE <= -8.25 D in the eye to be treated in patients who are 22 years of age or older with documentation of stable manifest refraction over the past year as demonstrated by a change of <= 0.50 D MRSE.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code OTL (Femtosecond laser system for refractive correction).
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Carl Zeiss Meditec, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- CLARUS (700)510(k)
K243878 · Decided Apr 17, 2025 · 120 days after receipt
Device type: Camera, Ophthalmic, Slit-Scanning (QER) · Ophthalmology
- MEL90PMA supplement
P060004-S006 · Decided Dec 4, 2024 · 471 days after receipt · Panel Track
Device type: Excimer laser system (LZS) · Ophthalmology
K233933 · Decided May 17, 2024 · 155 days after receipt
Device type: Tomography, Optical Coherence (OBO) · Ophthalmology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.